Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
Clinical trial NCT06328036 · WITHDRAWN
Trial details
- NCT number
- NCT06328036
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-30
- Primary completion
- 2025-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.